chr4-185370805-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001377440.1(LRP2BP):āc.813C>Gā(p.Asp271Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,461,830 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001377440.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRP2BP | NM_001377440.1 | c.813C>G | p.Asp271Glu | missense_variant | 8/9 | ENST00000505916.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRP2BP | ENST00000505916.6 | c.813C>G | p.Asp271Glu | missense_variant | 8/9 | 2 | NM_001377440.1 | P1 | |
LRP2BP | ENST00000328559.11 | c.813C>G | p.Asp271Glu | missense_variant | 7/8 | 1 | P1 | ||
LRP2BP | ENST00000510776.5 | c.735C>G | p.Asp245Glu | missense_variant | 6/7 | 1 | |||
LRP2BP-AS1 | ENST00000514884.1 | n.81G>C | non_coding_transcript_exon_variant | 1/3 | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461830Hom.: 0 Cov.: 30 AF XY: 0.00000963 AC XY: 7AN XY: 727222
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.813C>G (p.D271E) alteration is located in exon 7 (coding exon 7) of the LRP2BP gene. This alteration results from a C to G substitution at nucleotide position 813, causing the aspartic acid (D) at amino acid position 271 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at